Brief: Collegium Pharmaceutical Q3 Revenue USD 159.3 Million Vs. IBES Estimate USD 155.6 Million
07/11/2024 21:02
Nov 07 (Reuters) - Collegium Pharmaceutical Q3 adjusted EBITDA USD 105.1 million vs. IBES estimate USD 98.1 million. * Q3 net income USD 9.3 million
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%